Popular diabetes and weight-loss drug may reduce risk of Alzheimer’s disease Post author: Post published: October 24, 2024 Post category:uncategorized Researchers have found that semaglutide may lower the risk of Alzheimer’s disease in people with type 2 diabetes (T2D). You Might Also Like Multiple myeloma mortality rates decline with advances in targeted therapies April 29, 2026 New AI assistant streamlines initial psychiatric consultations for doctors May 26, 2026 Mapping the evolution of AI in organelle segmentation March 10, 2026